Sex‐Based Disparities in Index Cases of Familial Hypercholesterolemia in Vietnam: A Cross‐Sectional Study

Sex‐Based Disparities in Index Cases of Familial Hypercholesterolemia in Vietnam: A Cross‐Sectional Study

ABSTRACT Background and Aims Familial hypercholesterolemia (FH) is a substantial contributor to the development of atherosclerotic cardiovascular disease. Therefore, the primary focus of our study was to examine sex‐based disparities in clinical signs, atherosclerotic status, lipid profiles, and tre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ngoc‐Thanh Kim, Doan‐Loi Do, Mai‐Ngoc Thi Nguyen, Thanh‐Tung Le, Hong‐An Le, Thanh‐Huong Truong
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Health Science Reports
Subjects:	atherosclerotic cardiovascular disease familial hypercholesterolemia LDL‐C statins
Online Access:	https://doi.org/10.1002/hsr2.70579
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evolocumab safety and efficacy in hypercholesterolemia patients with or without diabetes: a retrospective real-world analysis
by: Sultan Ibrahim Alraddadi, et al.
Published: (2025-01-01)

Efficacy, side effects, adherence, affordability, and procurement of dietary supplements for treating hypercholesterolemia: a narrative review
by: Isabel von Känel-Cordoba, et al.
Published: (2024-11-01)

Exploring LDLR-APOB Interactions in Familial Hypercholesterolemia in the Vietnamese Population: A Protein-Protein Docking Approach
by: Ngoc-Thanh Kim, et al.
Published: (2024-11-01)

Response to the Letter to the Editor: The Potential Consideration of Implicit/Unconscious Gender Bias in Clinical Management Among Patients With Familial Hypercholesterolemia
by: Ngoc‐Thanh Kim, et al.
Published: (2025-07-01)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
by: A. I. Ershova, et al.
Published: (2015-09-01)

ANALYSIS OF THE TRADITIONAL RISK FACTORS INFLUENCE ON DEVELOPMENT OF ISCHEMIC HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2017-06-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Family hypercholesterolemia due to LDLR gene in Vietnamese children: characteristics of phenotype and genotype
by: Mai Thi Thanh Do, et al.
Published: (2025-06-01)

The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia
by: Abdullah Al-Ashwal, et al.
Published: (2024-11-01)

Genetic Spectrum of Lithuanian Familial Hypercholesterolemia Patients
by: Urte Aliosaitiene, et al.
Published: (2025-05-01)

Familial hypercholesterolemia in patients with hypertension: the China H-type Hypertension Registry Study
by: Tianzhou Shen, et al.
Published: (2025-03-01)

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)
by: M. V. Yezhov, et al.
Published: (2019-06-01)

Karotid Endarterektomi geçiren hastalarda kontrolsüz diyabetin statin kullanan ve kullanmayan hastalarda LDL seviyelerine etkisi
by: Ateş Duman, et al.
Published: (2016-06-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

Homozygous familial hypercholesterolemia: case report of a rare cause of dyslipidemia Homozygotyczna rodzinna hipercholesterolemia. Opis przypadku dotyczący rzadkich przyczyn dyslipidemii
by: Cresio Alves, et al.
Published: (2011-09-01)

Association of sdLDL-C/LDL-C ratio with atherosclerotic cardiovascular disease: a case-control study
by: Yuxin Yang, et al.
Published: (2025-06-01)

LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world data
by: Torunn Melnes, et al.
Published: (2025-06-01)

Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*
by: Borislav Borissov, et al.
Published: (2017-01-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity
by: Amal Chamli, et al.
Published: (2023-03-01)

School-based universal screening for hypercholesterolemia in children
by: Chang-Hsien Yu, et al.
Published: (2022-07-01)

Hypercholesterolemia, as a Predictor Factor of Severe Acute Pancreatitis
by: Bogdan Socea, et al.
Published: (2018-12-01)

Association between outdoor artificial light at night, circadian health, and LDL-C in intracranial artery atherosclerotic stenosis
by: Le Yang, et al.
Published: (2025-07-01)

New experimental possibilities for statin myopathy diagnosing
by: E. V. Vinogradova, et al.
Published: (2021-07-01)

Therapeutic Management of LDL-C: Efficacy and Economic Impact Assessment
by: Abdallah Elshafeey
Published: (2025-05-01)

Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01)

Low-Density Lipoprotein Cholesterol as a Protective Factor in COPD and Implications for Statin Therapy: A Multi-Omics Genetic Epidemiology Study
by: Du T, et al.
Published: (2025-07-01)

Factors affecting marine economic development: evidence from central coastal provinces, Vietnam
by: Doan Thuan Nguyen, et al.
Published: (2025-01-01)

Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in Taiwan
by: Kuan-Chieh Tu, et al.
Published: (2025-03-01)

Sex and racial differences in prevalence and clinical characteristics of people living with LDLR and PCSK9 familial hypercholesterolemia genetic variants: Data from the All of Us Research program
by: Jeffery Osei, et al.
Published: (2025-06-01)

Global scientific trends in hypercholesterolemia research from 2003 to 2023: a data-driven bibliometric and visual analysis
by: Haoxin Guo, et al.
Published: (2025-06-01)

The role of leadership and organizational learning in fostering high performance of tourism firms in Vietnam
by: Ngoc Khuong Mai, et al.
Published: (2023-12-01)

The Importance of Genetic Testing for Familial Hypercholesterolemia: A Pediatric Pilot Study
by: Andreea Teodora Constantin, et al.
Published: (2024-09-01)

ANTI-HYPERCHOLESTEROLEMIA ACTIVITY OF ETHANOL EXTRACT Peperomia pellucid
by: Chasanah Mazroatul, et al.
Published: (2016-03-01)

Dietary Approach in Familial Hypercholesterolemia
by: Joanna Popiolek-Kalisz, et al.
Published: (2025-01-01)

The impact of the nocebo effect on discontinuation of statin therapy due to myopathy in patients with cardiovascular disease – a review
by: Jakub Stanek, et al.
Published: (2024-11-01)

Effectiveness of Food Cholesterol Detect (FCD) Application on Total Cholesterol Levels of Hypercholesterolemia Patients
by: Terati Terati, et al.
Published: (2025-03-01)

Monitoring of bone matrix acidification by TRAP and ERK biomarkers in the chronic hypercholesterolemia male rats
by: Duaa Raad Abd-Al-Ameer, et al.
Published: (2024-08-01)

Molecular diagnosis methods in familial hypercholesterolemia
by: Valeriu Moldovan, et al.
Published: (2020-02-01)

Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents
by: Aynur Küçükçongar Yavaş, et al.
Published: (2017-03-01)